Aura Biosciences Inc (AURA)
Healthcare
Biotechnology
7.00 $
-1.4%
vs. previous close
Closing price · As of: 31. Jul 2026
Aura Biosciences Inc (AURA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -30 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -15 | -15 | -17 | -24 | -16 | -15 | -24 | -23 | -21 | -20 | -20 | -30 | -91 | |
| 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | 1.1 | |
| 1.9 | 2.3 | 2.6 | 2.9 | 3.1 | 2.8 | 2.9 | 3.5 | 3.8 | 3.7 | 3.3 | 3.8 | 15 | |
| 0.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.1 | 0.8 | 2.0 | -6.8 | 1.7 | 3.4 | -0.9 | 0.4 | 2.0 | 2.0 | 1.6 | -0.4 | 5.1 | |
| 0.2 | 0.1 | 0.3 | 0.1 | 0.5 | 0.3 | 0.3 | 0.2 | 0.0 | 0.0 | 0.2 | 0.1 | 0.4 | |
| 21 | 22 | -90 | 9.4 | 20 | 9.9 | 30 | 30 | 20 | -44 | 30 | 55 | 61 | |
| 0.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.5 | 1.6 | 93 | 0.3 | 0.1 | 0.7 | 0.5 | 0.1 | 70 | 4.4 | 2.8 | 0.3 | 77 | |
| 9.2 | 7.9 | -15 | -15 | 3.8 | -4.7 | 6.3 | 6.5 | 69 | -60 | 12 | 25 | 47 | |
| -15 | -15 | -18 | -25 | -17 | -16 | -24 | -24 | -21 | -20 | -21 | -30 | -92 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.